Musculoskeletal manifestations in beta 2-microglobulin amyloidosis. Case discussion

Ellen M. Gravallese, University of Massachusetts Medical School
Nancy Baker, Harvard Medical School
Susan Lester, Brigham and Women’s Hospital
Jonathan Kay, Harvard Medical School
William F. Owen Jr, Harvard Medical School

At the time of publication, Ellen Gravallese was not yet affiliated with the University of Massachusetts Medical School


The cases presented illustrate some of the typical (case 1) and less common (case 2) clinical features of beta 2m amyloidosis. The accumulation of beta 2m amyloid in tissues is a potentially severe complication of dialysis-treated chronic renal failure. Beta 2m amyloidosis has been shown to have distinct clinical, radiologic, and pathologic features. The pathogenesis of this condition is not yet clearly understood, and recommendations for the clinical management of these patients at present are limited to recognition of the disease and symptomatic treatment. Further insights into the biology of this disease should lead to new strategies for prevention and treatment.